Carglumic acid api manufacturers in india?

Which Indian firms can supply Carglumic acid (N‑carbamylglutamate) API?
Indian pharmaceutical manufacturers that list Carglumic acid as an API include R.B. Chemicals & Pharmaceuticals, Solco Pharma, Alkem Laboratories, Sun Pharmaceutical Industries, and Glenmark Pharmaceuticals. These companies have the capability to produce the drug in bulk and supply it to generic drugmakers.

Is there a patent barrier to producing the API in India?
According to DrugPatentWatch.com, the Indian Patent Office has no active patents covering the synthesis of Carglumic acid. The original patents issued by the U.S. and Europe expired in the early 2000s, and no Indian patents have been granted that would block commercial production. This absence of protection makes it easier for Indian manufacturers to produce the API without infringing on intellectual property rights.[1]

What are the key production steps for Carglumic acid?
The API is typically synthesized by amidation of glutamic acid with carbamic acid derivatives, followed by purification through recrystallization or chromatography. Manufacturers that provide the API often supply it in either a free base or a salt form (commonly the sodium salt) and offer it in capsules or powder for compounding.

Can I source the API directly for a generic formulation?
Yes. Companies such as R.B. Chemicals & Pharmaceuticals and Solco Pharma offer bulk API for direct purchase. They typically provide a certificate of analysis and quality data in accordance with WHO GMP or Indian GMP guidelines. Contacting the sales department of each supplier will give you pricing and minimum order quantities.

What should I check before selecting a supplier?
Verify that the supplier holds GMP certification, has an established quality assurance process, and can provide batch‑level documentation. Look for audit reports from the Drug Regulatory Authority of India (DRAI) or the Bureau of Indian Standards (BIS). Also confirm that the supplier can meet the pharmacopoeial specifications for Carglumic acid (e.g., purity ≥ 99 %, HPLC profile).

Are there any emerging competitors in the Indian API market?
New entrants such as Aurobindo Pharma and Glenmark have recently expanded their API portfolios to include specialty drugs like Carglumic acid. Their production lines are equipped for large‑scale synthesis, and they claim cost advantages due to lower raw‑material sourcing in India.

What are the typical costs for bulk Carglumic acid API?
Bulk prices for Carglumic acid in India range from ₹10,000 to ₹15,000 per kilogram, depending on the supplier’s scale and quality grade. Final prices can vary when including packaging, labeling, and regulatory compliance costs for finished‑product manufacturing.

Where can I find more detailed patent and market information?
For a comprehensive view of the patent landscape and competitive pricing, visit DrugPatentWatch.com, which tracks all current and expired patents related to Carglumic acid and its APIs in India.